Keyword: Kindred Biosciences

Pet-drug developer Kindred Biosciences is launching a pilot field study to test molecules in dogs with atopic dermatitis, bolstering its commitment to R&D even after an early failure in the field.

Kindred Biosciences chalked up good results from its pivotal trial of KIND-010 to treat appetite problems in cats.